Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

Share Price is delayed by 15 minutes
Get Live Data
60.20    1.40 (2.38%)
Bid:
59.80
Ask:
60.80
Spread: 1.00 (1.672%)
Market Cap: £2.40b
OMU Live PriceLast checked at - London Stock Exchange

Intraday Old Mutual Lim. Share Chart

Trading Statement

12 Mar 2024 07:00

RNS Number : 4250G
Old Mutual Limited
12 March 2024
 

Old Mutual Limited

Incorporated in the Republic of South Africa

Registration number: 2017/235138/06

ISIN: ZAE000255360

LEI: 213800MON84ZWWPQCN47

JSE Share Code: OMU

LSE Share Code: OMU

NSX Share Code: OMM

MSE Share Code: OMU

ZSE Share Code: OMU

("Old Mutual" or "Company" or "Group")

 

Ref: 14/24

12 March 2024

 

OLD MUTUAL TRADING STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2023

 

Investors are advised that Old Mutual is currently in the process of finalising its results for the year ended 31 December 2023 ("current period"), which will be released on the Stock Exchange News Service of the JSE Limited on Wednesday, 27 March 2024. The ranges provided in this trading statement are relative to the results for the year ended 31 December 2022 ("comparative period") prepared on an IFRS 17 basis.

This trading statement provides an indication of a range for headline earnings per ordinary share ("HEPS") and earnings attributable to equity holders of the Group per ordinary share ("EPS") in terms of paragraph 3.4(b) of the JSE Limited Listings Requirements compared to the comparative period.

Old Mutual recorded robust results from operations ("RFO") growth due to strong operational performance underpinned by exceptional growth in new business and value of new business as we continue to gain market share across our segments.

Adjusted headline earnings ("AHE") growth was further bolstered by increased shareholder investment returns as a result of increased interest rates and a recovery in equity markets.

We exclude the Zimbabwe profits from AHE as the economy is currently hyperinflationary resulting in earnings volatility. The main contributor to the higher level of growth in headline earnings relative to AHE is higher shareholder portfolio profits in the Zimbabwean business.

Investors are advised that the Group's key profit measures are expected to be within the ranges outlined below:

Key profit measures

(R million unless stated otherwise)

 

Estimated

% change

 

Estimated

31 December 2023

IFRS17 unaudited results for the year ended

31 December 2022

RFO ¹

6% to 26%

7 749 to 9 211

7 310

AHE 2

13% to 33%

5 481 to 6 451

4 850

Adjusted headline earnings per share ("AHEPS") (cents) 3

14% to 34%

121.3 to 142.6

106.4

Headline earnings

16% to 36%

6 792 to 7 963

5 855

HEPS (cents)

18% to 38%

152.5 to 178.3

129.2

IFRS profit after tax attributable to equity holders of the parent

25% to 45%

6 540 to 7 586

5 232

Basic EPS (cents)

27% to 47%

146.7 to 169.8

115.5

 

1 RFO is the primary measure of the operating business performance of the Group's segments.

2 AHE is the Group's primary profit metric.

3 HEPS is defined as AHE divided by the weighted average number of ordinary shares adjusted to reflect the Group's B-BBEE shares.

 

The current period results are prepared on an IFRS 17 basis whereas the results for the comparative period were prepared on an IFRS 4 basis. The release of our 30 June 2023 interim results was accompanied by an IFRS 17 bridging pack which provided the comparative period numbers on both an IFRS 4 and IFRS 17 basis. It is not expected that results will differ by 20% or more when compared to previously disclosed comparative period results under IFRS 4 which are disclosed in Annexure A hereto.

 

The financial information in this trading statement is the responsibility of the Old Mutual Limited Board of Directors and has not been reviewed or reported on by the Group's external auditors.

Sandton

 

Sponsors

JSE

Tamela Holdings (Proprietary) Limited

Namibia

PSG Wealth Management (Namibia) (Proprietary) Limited

Zimbabwe

Imara Capital Zimbabwe plc

Malawi

Stockbrokers Malawi Limited

 

 

Enquiries

Investor Relations

Langa Manqele

Head of Investor Relations

M: +27 82 295 9840

E: investorrelations@oldmutual.com

Communications

Wendy Tlou

Interim Chief Communications Officer

M: +27 83 301 9663

E: oldmutualnews@oldmutual.com

 

Notes to Editors

About Old Mutual Limited

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key market segments in 14 countries. Old Mutual's primary operations are in Africa, and it has a niche business in China. With over 178 years of heritage across sub-Saharan Africa, Old Mutual is a crucial part of the communities it serves as well as broader society on the continent.

 

For further information on Old Mutual and its underlying businesses, please visit the corporate website at www.oldmutual.com.

 

 

 

 

Annexure A

 

 

31 December 2022

Key profit measures

(R million unless stated otherwise)

IFRS17 unaudited results for the year ended

IFRS 4

published results for the year ended

RFO

7 310

8 743

AHE

4 850

6 371

AHEPS (cents)

106.4

139.8

Headline earnings

5 855

7 948

HEPS (cents)

129.2

180.1

IFRS profit after tax attributable to equity holders of the parent

5 232

7 325

Basic EPS (cents)

115.5

166.0

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUAARRSNUOAUR
Date   Source Headline
15th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
11th Nov 20221:30 pmRNSForm 8.3 - Mediclinic International plc
4th Nov 20223:10 pmRNSOld Mutual Bula Tsela Transaction
20th Oct 202212:00 pmRNSForm 8.3 - Mediclinic International plc
14th Oct 202211:00 amRNSForm 8.3 - Mediclinic International plc
13th Oct 202212:30 pmRNSForm 8.3 - Mediclinic International plc
12th Oct 20221:00 pmRNSForm 8.3 - Mediclinic International plc
6th Oct 202212:30 pmRNSForm 8.3 - Mediclinic International plc
29th Sep 20221:30 pmRNSForm 8.3 - Mediclinic International plc
29th Sep 20221:00 pmRNSDirectorate Change
23rd Sep 20223:00 pmRNSForm 8.3 - Mediclinic International plc
6th Sep 202210:30 amRNSDirector/PDMR Shareholding
6th Sep 20229:30 amRNSInterim Dividend Currency Equivalents
30th Aug 20227:00 amRNSUnaudited Interim Results and Dividend Declaration
19th Aug 20222:00 pmRNSForm 8.3 - Mediclinic International plc
16th Aug 202212:40 pmRNSForm 8.3 - Mediclinic International plc
12th Aug 20221:30 pmRNSForm 8.3 - Mediclinic International plc
12th Aug 20221:00 pmRNSResults of shareholder voting at GM
11th Aug 20227:00 amRNSTrading Statement
4th Aug 202212:00 pmRNSForm 8.3 - Mediclinic International plc
27th Jul 20222:30 pmRNSForm 8.3 - Mediclinic International plc
26th Jul 20224:00 pmRNSDirectorate Change
26th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
25th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
19th Jul 20222:00 pmRNSForm 8.3 - Mediclinic International plc
18th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Jul 202211:15 amRNSLiving Hands Trust Matter
13th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
13th Jul 202212:00 pmRNSDistribution of circular including notice of GM
7th Jul 20221:30 pmRNSForm 8.3 - Mediclinic International plc
24th Jun 20223:30 pmRNSHolding(s) in Company
23rd Jun 20222:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Jun 20222:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Jun 202211:45 amRNSOMLACSA new financial instrument
20th Jun 20223:00 pmRNSForm 8.3 - Mediclinic International plc
16th Jun 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Jun 20221:00 pmRNSForm 8.3 - Mediclinic International plc
13th Jun 20221:00 pmRNSForm 8.3 - Mediclinic International plc
10th Jun 20224:00 pmRNSForm 8.3 - Mediclinic International plc
6th Jun 20223:45 pmRNSDisposal of Securities by BlackRock. Inc
27th May 202212:15 pmRNSResult of AGM
26th May 202211:00 amRNSOld Mutual Voluntary Operating Update
26th Apr 20222:30 pmRNSNotice of AGM
26th Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Apr 20221:30 pmRNSDealings in Securities
25th Apr 202210:10 amRNSDealings in securities
22nd Apr 20227:00 amRNSRelease of the IR and investor engagement
20th Apr 20222:00 pmRNSOML proposed Bula Tsela B-BBEE transaction
14th Apr 20223:00 pmRNSDealings in Securities on behalf of ESIS
14th Apr 20229:00 amRNSDealings in securities on behalf of ESIS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.